Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Luke A. Hyder"'
Autor:
Leanne M Johnson-Huang, Cara A Pensabene, Kejal R Shah, Katherine C Pierson, Toyoko Kikuchi, Tim Lentini, Patricia Gilleaudeau, Mary Sullivan-Whalen, Inna Cueto, Artemis Khatcherian, Luke A Hyder, Mayte Suárez-Fariñas, James G Krueger, Michelle A Lowes
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30308 (2012)
UnlabelledTo understand the development of new psoriasis lesions, we studied a group of moderate-to-severe psoriasis patients who experienced a relapse after ceasing efalizumab (anti-CD11a, Raptiva, Genentech). There were increased CD3(+) T cells, ne
Externí odkaz:
https://doaj.org/article/3578f6aa939e4e8fb1132dc90435b9aa
Autor:
Michelle A. Lowes, Narat John Eungdamrong, Jamie L. Harden, Nicholas Gulati, Judilyn Fuentes-Duculan, Luke A. Hyder, Juana Gonzalez, Katherine C. Pierson, Leanne M. Johnson-Huang, Lisa C. Zaba, Tim Lentini, Mayte Suárez-Fariñas
Publikováno v:
The Journal of investigative dermatology
Our group recently described a population of antigen-presenting cells that appear to be critical in psoriasis pathogenesis, termed inflammatory myeloid dendritic cells (CD11c(+)/blood dendritic cell (DC) antigen 1(-)). Triggering receptor expressed o
Autor:
Luke A. Hyder, Michelle A. Lowes, Leanne M. Johnson-Huang, Katherine C. Pierson, Cara A. Pensabene, Mayte Suárez-Fariñas, Mary Sullivan-Whalen, Inna Cueto, Tim Lentini, James G. Krueger, Patricia Gilleaudeau, Kejal R. Shah, Toyoko Kikuchi, Artemis Khatcherian
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30308 (2012)
PLoS ONE
PLoS ONE
UnlabelledTo understand the development of new psoriasis lesions, we studied a group of moderate-to-severe psoriasis patients who experienced a relapse after ceasing efalizumab (anti-CD11a, Raptiva, Genentech). There were increased CD3(+) T cells, ne